Dr. Michael Patrick O'Quinn, MD

Dr. O'Quinn practices at Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System.

Dr. O'Quinn's NPI, 1073807541, was assigned on June 2, 2011. Dr. O'Quinn holds South Carolina license 33606.

Dr. O'Quinn's primary practice is Spartanburg Medical Center, at 101 E Wood St, Spartanburg, SC 29303 in Spartanburg County. The practice phone is (864) 560-6554.

Dr. O'Quinn's primary practice is Spartanburg Medical Center in Spartanburg, South Carolina, part of Spartanburg Regional Healthcare System. Dr. O'Quinn is also affiliated with Mission Hospital. The medical group on file is Mission Health Community Multispecialty Providers. Dmand AI also links Dr. O'Quinn to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Quinn practices, 5 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. O'Quinn's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. O'Quinn is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. O'Quinn's licenses on file in 2 states: South Carolina and North Carolina.

CMS data shows 1,821 Medicare services from Dr. O'Quinn across 25 procedure codes in 2024, for 403 Medicare patients. Medicare paid $167,546 for them.

CMS counts 403 Medicare patients who saw Dr. O'Quinn in 2024. The largest group is 75 to 84, with 188 patients. 75% of them have atrial fibrillation, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. O'Quinn's median patient age at 77, with 50% women.

In 2024, Dr. O'Quinn wrote 823 Medicare Part D claims for 308 patients. 76% of them were for generic drugs. CMS names the drug for 669 of them, across 15 drugs with 11 or more claims each, at $165,627 in total drug cost. In 2023, CMS named 1,331 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. O'Quinn for performance year 2024, reported through an alternative payment model (APM). Dr. O'Quinn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 49 procedures of pacemaker insertion or repair by Dr. O'Quinn, more than 89% of the clinicians it reports for that procedure.

CMS Open Payments shows 510 general payments to Dr. O'Quinn from 39 drug and device companies from 2016 to 2025. Grants make up the largest share, 42% of the total. Medtronic Vascular, Inc. paid the most, $48,188.